ON USING THE LINEAR-QUADRATIC MODEL IN DAILY CLINICAL-PRACTICE

被引:73
作者
YAES, RJ
PATEL, P
MARUYAMA, Y
机构
[1] University of Kentucky Medical Center, Lexington
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1991年 / 20卷 / 06期
关键词
ISOEFFECT DOSE; SURVIVAL CURVE; BRACHYTHERAPY; NSD; TIME; DOSE; FRACTIONATION;
D O I
10.1016/0360-3016(91)90249-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To facilitate its use in the clinic, Barendsen's formulation of the Linear-Quadratic (LQ) model is modified by expressing isoeffect doses in terms of the "Standard Effective Dose," D(s), the isoeffective dose for the "standard" fractionation schedule of 2 Gy fractions given once per day, 5 days per week. For any arbitrary fractionation schedule, where total dose D is given in N fractions of size d in a total time T, the corresponding "Standard Effective Dose," D(s), will be proportional to the total dose D and the proportionality constant will be called the "Standard Relative Effectiveness," SRE, to distinguish it from Barendsen's "Relative Effectiveness," RE. Thus, D(s) = SRE.D. The constant SRE depends on the parameters of the fractionation schedule, and on the tumor or normal tissue being irradiated. For the "simple" LQ model with no time dependence, which is applicable to late reacting tissue, SRE = [(d + delta)/(2 + delta)], where d is the fraction size and delta = alpha/beta is the alpha/beta-ratio for the tissue of interest, with both d and delta-expressed in units of Gy. Application of this method to the Linear Quadratic model with a time dependence, the "LQ + time" model, and to low dose rate brachytherapy will be discussed. To clarify the method of calculation, and to demonstrate its simplicity, examples from the clinical literature will be used.
引用
收藏
页码:1353 / 1362
页数:10
相关论文
共 44 条
[21]   DOSE FRACTIONATION AND REGENERATION IN RADIOTHERAPY FOR CANCER OF THE ORAL CAVITY AND OROPHARYNX .2. NORMAL TISSUE RESPONSES - ACUTE AND LATE EFFECTS [J].
MACIEJEWSKI, B ;
WITHERS, HR ;
TAYLOR, JMG ;
HLINIAK, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 18 (01) :101-111
[22]   DISTRIBUTION OF RADIATION SENSITIVITIES FOR HUMAN-TUMOR CELLS OF SPECIFIC HISTOLOGICAL TYPES - COMPARISON OF INVITRO TO INVIVO DATA [J].
MALAISE, EP ;
FERTIL, B ;
CHAVAUDRA, N ;
GUICHARD, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (04) :617-624
[23]  
MILLER J, 1989, 17TH P INT C RAD PAR
[24]   SIMPLIFICATION IN USE OF NSD CONCEPT IN PRACTICAL RADIOTHERAPY [J].
ORTON, CG ;
ELLIS, F .
BRITISH JOURNAL OF RADIOLOGY, 1973, 46 (547) :529-537
[25]  
PEREZ CA, 1983, CANCER, V51, P1393, DOI 10.1002/1097-0142(19830415)51:8<1393::AID-CNCR2820510812>3.0.CO
[26]  
2-M
[27]   THE BUSCHKE,FRANZ LECTURE - LATE EFFECTS OF CHEMOTHERAPY AND RADIATION-THERAPY - A NEW HYPOTHESIS [J].
RUBIN, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (01) :5-34
[28]   CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY IN LOCALLY ADVANCED-CARCINOMA OF THE HEAD AND NECK REGION [J].
SAUNDERS, MI ;
DISCHE, S ;
HONG, A ;
GROSCH, EJ ;
FERMONT, DC ;
ASHFORD, RFU ;
MAHER, EJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (06) :1287-1293
[29]   THERAPEUTIC IRRADIATION AND BRAIN INJURY [J].
SHELINE, GE ;
WARA, WM ;
SMITH, V .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (09) :1215-1228
[30]  
Strandquist M., 1944, ACTA RADIOL, P1